Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial

The aim of this study was to evaluate the correlation between uptake of the PET ligand (68)Ga-NOTA-AE105, targeting the urokinase-type plasminogen activator receptor (uPAR), and Gleason score in patients undergoing prostate biopsy. Methods: Patients with clinical suspicion of prostate cancer (PCa) o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Fosbøl, Marie Øbro, Kurbegovic, Sorel, Johannesen, Helle Hjorth, Røder, Martin Andreas, Hansen, Adam Espe, Mortensen, Jann, Loft, Annika, Petersen, Peter Meidahl, Madsen, Jacob, Brasso, Klaus, Kjaer, Andreas
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8049344/
https://ncbi.nlm.nih.gov/pubmed/32764119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.120.248120
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados